Table 4.
Action Taken in Controlled vs Uncontrolled Patients
| Controlled Patients,a No. (%) (n=127) | Uncontrolled Patients,b No. (%) (n=784) | P Value | |
|---|---|---|---|
| Dose unchanged and no drug added | 99 (73.3) | 322 (40.7) | <.001 |
| Dose increased | 10 (7.4) | 237 (29.9) | <.001 |
| Dose decreased | 7 (5.2) | 9 (1.1) | .003 |
| Addition of antihypertensive drug | 11 (8.1) | 212 (26.8) | <.001 |
| RAS inhibitor | 6/11 (54.5) | 88/212 (41.5) | .533 |
| Diuretic | 8/11 (72.7) | 60/212 (28.3) | .004 |
| β‐Blocker | 1/11 (9.1) | 25/212 (11.8) | 1.000 |
| Calcium channel blocker | 2/11 (18.2) | 75/212 (35.4) | .338 |
| Others | 0/11 (0.0) | 19/212 (9.0) | .605 |
Eight patients did not have sufficient information to allow assessment of control.
a
Displayed all of the following: mean blood pressure (BP) <130/85 mm Hg, daytime BP <135/85 mmHg, and nighttime BP <120/70 mm Hg.
b
At least one of the mean, daytime, and nighttime BP values was above the defined value for control.
Abbreviation: RAS, renin‐angiotensin system.